Skip to content

Effectiveness of SARPE With 3 and 2-Segment Technique: A Randomized Clinical Trial

Effectiveness of Surgically Assisted Rapid Palatal Expansion (SARPE) With 3 and 2-Segment Technique: A Randomized Clinical Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02179593
Acronym
3S/2S_SARPE
Enrollment
50
Registered
2014-07-02
Start date
2013-09-30
Completion date
2016-12-31
Last updated
2016-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Maxillary Hypoplasia

Keywords

Maxillary expansion, Orthognathic surgery, Symmetry, Palatal expansion technique, Maxilla abnormality

Brief summary

A few studies state that 3-segment SARPE has the following advantages: a) higher level of expansion symmetry; b) higher level of stability of the expansion achieved; and c) faster bone healing. The investigators hypothesize that 2-segment SARPE is as effective as 3-segment SARPE concerning treatment and/or quality of life in daily practice.

Detailed description

32 healthy, literate adult patients (male and female) with 7-millimeter transverse maxilla deficiency bilaterally distributed will participate in this study. The participants will be assigned randomizable in equal number to undergo either 3-segment or 2-segment SARPE. Individuals that a) have undergone maxilla surgery previously; b) have craniofacial anomaly;and c) have dental crowding will not be enrolled. All participants will be assessed before and after surgery for sensitivity to pressure and temperature in the innervated structures linked to the maxilla, as well as for quality of life using OHIP-49 and B-OQLQ assessment tools. The expansion of maxilla will be assessed by superimposing tomographic images before and after surgery.

Interventions

OTHER2-Segment SARPE

Le Fort I osteotomy with oppening of the median palatal suture and SARPE.

OTHER3-Segment SARPE

Le Fort I osteotomy with two parallel osteotomies symetrically positioned with reference to the median palatal suture and SARPE.

Sponsors

Federal University of São Paulo
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
17 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Being healthy and literate * Having 7-millimeter transverse maxilla deficiency bilaterally distributed.

Exclusion criteria

* Having undergone maxilla surgery previously * Having craniofacial anomaly * Having excessive dental crowding.

Design outcomes

Primary

MeasureTime frameDescription
Quality of LifeAn average of 2 weeks after expansion.The primary outcome chosen in this study is Quality of Life assessed through the Orthognathic Quality of Life Questionaire (OQLQ) and Oral Health Impact Profile (OHIP-49) currently available in Portuguese language and validated for scientific studies.

Secondary

MeasureTime frameDescription
Maxillary symmetrypre-operative and an average of 2 weeks at the end of maxillary expansion.The maxillary symmetry will be assessed by analyzing before and after 3D imaging obtained from computed tomography data , superimposed using the Geomagic Qualify software.
Stability of dental and osseous structurespre-operative, an average of 2 weeks at the end of the expansion, 4 months, 1 and 2 years after maxillary expansion.The stability of dental and osseous structures will be analyzed using computer-aided 3D analysis of data obtained through the scanning of dental casts using Bicam 3D scanner (Scaierman - Italy).
Nasal and paranasal topographic changespre-operative,an average of 2 weeks at the end of the expansion, 4 and 12 months after maxillary expansion.The nasal and paranasal topographic changes will be captured using laser scanner device.

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026